pain that is associated with arthritis.
4- People who perform repetitive motions involving the joints are also the most commonly affected by osteoarthritis. The pain is generally said to be at its worst during the night, after a long day of activity. Generally, the arthritis is accompanied by warming, swelling or creaking in the joints that are affected. Stiffness and pain are also reported by patients, usually after long periods of immobility.
5- There are several steps that can be taken to ease the discomfort of osteoarthritis. Over the counter pain medication, when taken in conjunction with weight loss efforts and exercise, is often all that is needed to control the pain. However, if this is not the case in your situation, speak with your doctor about other pain suppressing methods that may work better for you.
About the author:
John Mancini has been writing about Rheumatoid Arthritis online and offline for a long time. Visit http://stop-arthritis.net or http://arthritis-central.com to read more about matters like arthritis pain relief and arthritis treatment.
Written By: John Mancini

Medication fears lead to worse side effects - Vancouver Sun
NEW YORK - It may not be surprising, but a new study offers some proof that patients who are worried about their medications are more likely to have side effects from them. The study involved patients with a particular kind of arthritis. While more ...
Roche, Biogen Suspend Arthritis Drug Program After Patient Deaths - Daily Finance
An independent safety monitoring board recommended the pharmaceutical firms halt the program after concluding that the safety risks outweighed the benefits observed in some patients. Specifically, the board detected "serious and opportunistic ...
UPDATE 2-Roche suspends arthritis treatment after deaths - Reuters
ZURICH, March 8 (Reuters) - Swiss drugmaker Roche Holding AG ( ROG.VX ) and U.S.-listed Biogen Idec ( BIIB.O ) are suspending rheumatoid arthritis and lupus treatment ocrelizumab after it caused deaths, casting doubt over the drug's future. Roche and ...
UPDATE 4-Roche, Biogen suspends arthritis drug after deaths - Reuters
ZURICH, March 8 (Reuters) - Swiss drugmaker Roche Holding AG ( ROG.VX ) and U.S. biotechnology company Biogen Idec ( BIIB.O ) are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting ...
Roche, Biogen Idec Suspend Tests for Arthritis Drug (Update3) - BusinessWeek
March 8 (Bloomberg) -- Roche Holding AG and Biogen Idec Inc. are suspending development of the ocrelizumab treatment for use in arthritis after an independent monitoring board said safety risks outweigh benefits observed in these patients. The ...
Roche, Biogen suffer setback with rheumatoid arthritis drug - Marketwatch
ZURICH (MarketWatch) -- Roche Holding AG (ROG.VX) and Biogen Idec Inc (NASDAQ:BIIB) said Monday they suspended a rheumatoid arthritis program using drug candidate ocrelizumab because of safety concerns, further cutting the experimental drug's market ...
Major Pharmaceutical Company Stops Arthritis Study After Deaths - FOX News
Swiss pharmaceutical company Roche Group said Monday it has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from infections. Roche said the drug, ocrelizumab, was developed together with Biogen ...